{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T10:08:54Z","timestamp":1763201334772,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 92-2314-B-006-135"],"award-info":[{"award-number":["NSC 92-2314-B-006-135"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.urology.2005.08.034","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:05Z","timestamp":1139405105000},"page":"294-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer"],"prefix":"10.1016","volume":"67","author":[{"given":"Tzong-Shin","family":"Tzai","sequence":"first","affiliation":[]},{"given":"Yuh-Shyan","family":"Tsai","sequence":"additional","affiliation":[]},{"given":"Ai-Li","family":"Shiau","sequence":"additional","affiliation":[]},{"given":"Chao-Liang","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Gia-Shing","family":"Shieh","sequence":"additional","affiliation":[]},{"given":"Hsin-Tzu","family":"Tsai","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2005.08.034_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/1046-5928(90)90014-P","article-title":"Human prothymosin-\u03b1","volume":"1","author":"Sburlati","year":"1990","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.urology.2005.08.034_bib2","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/S0021-9258(19)67881-6","article-title":"Nuclear targeting of prothymosin-\u03b1","volume":"266","author":"Manrow","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2005.08.034_bib3","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1073\/pnas.88.15.6608","article-title":"Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ","volume":"88","author":"Clinton","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2005.08.034_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606534","article-title":"Immunohistochemical location of prothymosin alpha in regenerating human hepatocytes and hepatocellular carcinomas","volume":"423","author":"Fraga","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.urology.2005.08.034_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000147251","article-title":"Prothymosin alpha expression in lymph nodes and tonsils","volume":"143","author":"Gallego","year":"1992","journal-title":"Acta Anat"},{"key":"10.1016\/j.urology.2005.08.034_bib6","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/bi00068a015","article-title":"Phosphorylation of human and bovine prothymosin in vivo","volume":"32","author":"Sburlati","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.urology.2005.08.034_bib7","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.83.24.9403","article-title":"The human prothymosin-\u03b1 gene is polymorphic and induced upon growth stimulation","volume":"83","author":"Eschenfeldt","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2005.08.034_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ar.1092390110","article-title":"Distribution of prothymosin alpha in rat and human adrenal cortex","volume":"239","author":"Garc\u00eda-Caballero","year":"1994","journal-title":"Anat Rec"},{"key":"10.1016\/j.urology.2005.08.034_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00159285","article-title":"Evolution of prothymosin alpha and proliferating cell nuclear antigen (PCNA) immunoreactivity through the development of rat ovarian follicles","volume":"25","author":"Ros\u00f3n","year":"1993","journal-title":"Histochem J"},{"key":"10.1016\/j.urology.2005.08.034_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00271986","article-title":"Prothymosin alpha expression is associated to cell division in rat testis","volume":"94","author":"Ros\u00f3n","year":"1990","journal-title":"Histochemistry"},{"key":"10.1016\/j.urology.2005.08.034_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1177\/38.12.2254650","article-title":"Cellular distribution of prothymosin alpha and parathymosin in rat thymus and spleen","volume":"38","author":"Ros\u00f3n","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.urology.2005.08.034_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1073\/pnas.88.1.253","article-title":"Prothymosin \u03b1 antisense oligomers inhibit myeloma cell division","volume":"88","author":"Sburlati","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2005.08.034_bib13","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1073\/pnas.90.20.9504","article-title":"Expression of alpha-thymosins in human tissues in normal and abnormal growth","volume":"90","author":"Tsitsiloni","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2005.08.034_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0959-8049(05)80433-2","article-title":"Tissue concentrations of prothymosin alpha","volume":"29A","author":"Dom\u00ednguez","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2005.08.034_bib15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.onc.1202458","article-title":"Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections","volume":"18","author":"Tahara","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2005.08.034_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.ju.0000107826.78479.90","article-title":"Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer","volume":"171","author":"Shariat","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.08.034_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0090-4295(98)00219-2","article-title":"Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer","volume":"52","author":"Landman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.08.034_bib18","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1097\/01.ju.0000067461.30468.6d","article-title":"Tumor markers in the diagnosis of primary bladder cancer","volume":"169","author":"Glas","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.08.034_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0090-4295(97)00081-2","article-title":"Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder","volume":"49","author":"Ianari","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.08.034_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0090-4295(97)00292-6","article-title":"Improved detection of recurrent bladder cancer using the Bard BTA Stat test","volume":"50","author":"Sarosdy","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.08.034_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0090-4295(97)00508-6","article-title":"Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors","volume":"50","author":"Ellis","year":"1997","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950501191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950501191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:43:41Z","timestamp":1758764621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042950501191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S009042950501191X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2005.08.034","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2005.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}